Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

BRCA germline mutations in women with uterine serous carcinoma--still a debate.

International journal of gynecological cancer : official journal of the International Gynecological Cancer Society - 1 Dec 2010

Lavie Ofer, Ben-Arie Alon, Segev Yakir, Faro Jonathan, Barak Frida, Haya Nir, Auslender Ron, Gemer Ofer

Abstract excerpt

OBJECTIVE: To determine the incidence of BRCA1 and BRCA2 mutations in an enlarged series of uterine serous carcinoma (USC) patients and to determine whether patients with USC are associated with a personal or familial history of breast or ovarian carcinoma. METHODS: A cohort of all consecutive patients with diagnosed USC was identified for 9 years. Family pedigrees were drawn as far back and laterally as...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Incidence
Share to Cystadenocarcinoma, Serous

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Family Health

Share to Genes, BRCA1

Share to Genes, BRCA2

Share to Germ-Line Mutation

Share to Uterine Neoplasms

Source

Identifiers

PMID: 21119368
DOI: 10.1111/IGC.0b013e3181cd242f

Genes

BRCA1
BRCA2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

BRCA germline mutations in women with uterine serous carcinoma--still a debate.PMID 21119368Read ↗

BRCA1/2 germline mutations in Jewish patients with uterine serous carcinoma.Semantic proximity Read ↗

BRCA germline mutations in Jewish women with uterine serous papillary carcinoma.Semantic proximity Read ↗

High incidence of BRCA1–2 germline mutations, previous breast cancer and familial cancer history in Jewish patients with uterine serous papillary carcinomaSemantic proximity Read ↗

BRCA1 germline mutations in women with uterine serous papillary carcinoma.Semantic proximity Read ↗

BRCA1, TP53, and CHEK2 germline mutations in uterine serous carcinomaSemantic proximity Read ↗

Germline mutations of the DNA repair pathways in uterine serous carcinoma.Semantic proximity Read ↗

Peritoneal carcinoma in women with genetic susceptibility: implications for Jewish populations.Semantic proximity Read ↗

Risk of endometrial carcinoma associated with BRCA mutation.Semantic proximity Read ↗

Impact of BRCA mutations on outcomes among patients with serous endometrial cancer.Semantic proximity Read ↗

Fallopian tube and primary peritoneal carcinomas associated with BRCA mutations.Semantic proximity Read ↗

BRCA mutations and outcome in epithelial ovarian cancer (EOC): experience in ethnically diverse groups.Semantic proximity Read ↗

Ovarian cancer risk in Ashkenazi Jewish carriers of BRCA1 and BRCA2 mutations.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.